Biophysics in Drug Discovery 2018
Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Boston, USA June 13-15, 2018
University of California, San Francisco, CA, United States
Bristol-Myers-Squibb, Princeton, United States
New York Structural Biology Center, New York, United States
Eli Lilly, Indianapolis, United States
Carmot Therapeutics, South San Francisco, United States
NovAliX & Ribostruct, Illkirch, France
Abbvie, North Chicago, United States
Merck & Co., Inc., Morristown, United States